𝔖 Bobbio Scriptorium
✦   LIBER   ✦

L-Dopa–resistant parkinsonism due to dopa decarboxylase deficiency?

✍ Scribed by Joseph Januarykovic

Publisher
John Wiley and Sons
Year
1981
Tongue
English
Weight
193 KB
Volume
10
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeting dopa-sensitive and dopa-resist
Targeting dopa-sensitive and dopa-resistant gait dysfunction in Parkinson's disease: Selective responses to internal and external cues
✍ Lynn Rochester; Katherine Baker; Alice Nieuwboer; David Burn 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB

## Abstract ## Background: Independence of certain gait characteristics from dopamine replacement therapies highlights its complex pathophysiology in Parkinson's disease (PD). We explored the effect of two different cue strategies on gait characteristics in relation to their response to dopaminerg

Early-onset L-dopa-responsive parkinsoni
Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations
✍ Coro Paisán-Ruiz; Rocio Guevara; Monica Federoff; Hasmet Hanagasi; Fardaz Sina; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 359 KB 👁 1 views

## Abstract Seven autosomal recessive genes associated with juvenile and young‐onset Levodopa‐responsive parkinsonism have been identified. Mutations in __PRKN__, __DJ‐1__, and __PINK1__ are associated with a rather pure parkinsonian phenotype, and have a more benign course with sustained treatment

Comparison between the decrease of dopam
Comparison between the decrease of dopamine transporter and that of L-DOPA uptake for detection of early to advanced stage of Parkinson's disease in animal models
✍ Yasushi Ito; Masahiro Fujita; Shoichi Shimada; Yoshiyuki Watanabe; Tomoya Okada; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

Early diagnosis of Parkinson's disease (PD) is important for the potential application of neuroprotective therapies. The purpose of this study was to assess the detection of the early changes of PD by either imaging the dopamine transporter (DAT) or uptake of L-3,4-dihydroxyphenylalanine (L-DOPA). A